Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy

Keros Therapeutics, Inc. · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
duchenne-muscular-dystrophypharmacodynamicspharmacokinetics
duchenne muscular dystrophy, recombinant fusion protein, muscle-wasting disease, ambulatory function, pharmacokinetics, pharmacodynamics, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 910304
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.